LifeMD Inc. (LFMD)
LFMD trades on Nasdaq in Health Care, Medical/Nursing Services. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/948320/000149315226009549/0001493152-26-009549-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | LFMD on Nasdaq |
| Sector | Health Care |
| Industry | Medical/Nursing Services |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000948320 |
| SEC industry code | Services-Offices & Clinics of Doctors of Medicine |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $194.1M |
| Net income | $14.4M |
| Operating income | -$7.7M |
| Net margin | 7.4% |
| Operating margin | -4.0% |
| Revenue growth | +25.3% |
| Cash | $36.8M |
| Total assets | $70.4M |
| P/E (computed) | 6.2× |
| P/S (computed) | 0.5× |
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 10-Q 2026-11-12 |
| Cash and burn | $21.9M cash; operating cash flow -$2.7M a quarter. | Report 2026-09-30 |
| Shares outstanding | 48,333,837 (2026-11-11); 48,135,885 a year earlier; 37,978,804 three years earlier. | Cover page 2026-11-11 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers LLP, New York, New York, United States; changed auditors 2 times in 24 months | 8-K 4.01 2025-08-21 |
| Late filings, 12 months | 1 NT notice | NT 10-Q 2026-11-09 |
| Insider trades, 12 months | Bought $0, sold $54K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Quarterly results
| Quarter | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| Q3 2026 2026-09-30 | $44.6M | -$4.5M | -$950K | $21.9M | No debt tags | $189.3M | 10-Q 2026-11-12 |
| Q2 2026 2026-06-30 | $47.3M | -$7.1M | -$6.9M | $25.1M | No debt tags | $192.4M | 10-Q 2026-08-05 |
| Q1 2026 2026-03-31 | $50.2M | -$8.9M | $445K | $34.5M | No debt tags | $194.1M | 10-Q 2026-05-06 |
| Q4 2025 2025-12-31 | $47.2M | $20.8M | -$3.3M | $36.8M | No debt tags | $194.8M | 10-K 2026-03-10 |
| Q3 2025 2025-09-30 | $47.7M | -$3.9M | -$147K | $20.9M | No debt tags | $153.1M | 10-Q 2026-11-12 |
| Q2 2025 2025-06-30 | $49.0M | -$1.6M | $8.6M | $36.2M | $15.9M | $158.7M | 10-Q 2026-08-05 |
| Q1 2025 2025-03-31 | $50.9M | -$184K | $3.1M | $34.4M | $18.4M | $160.3M | 10-Q 2026-05-06 |
| Q4 2024 2024-12-31 | $5.5M | -$4.9M | $1.1M | $35.0M | $18.3M | $153.6M | 10-K 2026-03-10 |
From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2024-08-13 |
| Latest annual report | 10-K | 2026-03-10 |
| Latest quarterly / interim | 10-Q | 2026-11-12 |
| Latest current report | 8-K | 2026-11-12 |
| Latest proxy | DEFA14A | 2026-04-30 |
Source: SEC EDGAR submissions feed, 581 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -7.2% |
| 1 month | -10.9% |
| 3 months | -36.4% |
| Year to date | -35.5% |
| 1 year | -52.4% |
| From 52-week high | -58.3% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| LFMDP | LifeMD Inc. 8.875% Series A Cumulative Perpetual Preferred Stock | $19.48 |
Peers in Medical/Nursing Services
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NAKA | Nakamoto Inc. | $4.59 | -8.20% | $84.2M |
| AIRS | AirSculpt Technologies Inc. | $0.7000 | -16.37% | $51.7M |
| EUDA | EUDA Health Holdings Limited | $15.32 | -1.45% | $45.9M |
| ALPS | ALPS Group Inc Ordinary Share | $1.15 | -3.36% | $36.4M |
| AUNA | Auna SA | $4.63 | +0.87% | $342.7M |
| STLN | Starling Oncology Inc. | $3.54 | +1.14% | $361.0M |
| DCGO | DocGo Inc. | $0.1899 | -8.53% | $18.8M |
| PIII | P3 Health Partners Inc. | $2.41 | -10.74% | $17.5M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier